Nomura Holdings’s Relay Therapeutics RLAY Stock Holding History

Nomura Holdings’s Portfolio RLAY Stock Details RLAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-25,000	Closed	-$249K	–	2012
2026 Q1	$249K	Buy	+25,000	New	+$224K	﹤0.01%	1526

Other funds holding RLAY

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Nomura Holdings's RLAY Position: Q2 2026 in Review

Nomura Holdings sold out of Relay Therapeutics (RLAY) in Q2 2026, closing a stake of 25,000 shares — an estimated $249K sold.

Nomura Holdings first reported a position in RLAY in Q1 2026 and held it in 1 quarter. The position peaked at $249K in Q1 2026. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

Nomura Holdings reported no remaining Relay Therapeutics position as of Q2 2026 after selling out during the quarter.
Nomura Holdings sold 25,000 Relay Therapeutics shares in Q2 2026, an estimated $249K.
Nomura Holdings first reported a position in Relay Therapeutics in Q1 2026 and held it in 1 quarter.
Nomura Holdings's Relay Therapeutics position peaked at $249K in Q1 2026.
259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.